Neoplasms by Site Not Yet Recruiting Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0030096 (Neoplasms by Site)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04807166Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian CancerTreatment